P101 (0149) PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA

Bibliographic Details
Format: Article
Language:English
Published: Wiley 2018-10-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000547945.22145.f7
_version_ 1797285856560545792
collection DOAJ
first_indexed 2024-03-07T18:09:26Z
format Article
id doaj.art-3716c4bc3fe045558bae2c23882f96d0
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:09:26Z
publishDate 2018-10-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-3716c4bc3fe045558bae2c23882f96d02024-03-02T07:47:33ZengWileyHemaSphere2572-92412018-10-0124010.1097/01.HS9.0000547945.22145.f7201810003-00102P101 (0149) PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMAhttp://journals.lww.com/10.1097/01.HS9.0000547945.22145.f7
spellingShingle P101 (0149) PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA
HemaSphere
title P101 (0149) PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA
title_full P101 (0149) PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA
title_fullStr P101 (0149) PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA
title_full_unstemmed P101 (0149) PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA
title_short P101 (0149) PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN PLUS AVD IN PEDIATRIC PATIENTS WITH ADVANCED STAGE NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA
title_sort p101 0149 phase 1 2 study of brentuximab vedotin plus avd in pediatric patients with advanced stage newly diagnosed classical hodgkin lymphoma
url http://journals.lww.com/10.1097/01.HS9.0000547945.22145.f7